CN103750318B - 明日叶混合软胶囊及其制备方法 - Google Patents
明日叶混合软胶囊及其制备方法 Download PDFInfo
- Publication number
- CN103750318B CN103750318B CN201410020286.XA CN201410020286A CN103750318B CN 103750318 B CN103750318 B CN 103750318B CN 201410020286 A CN201410020286 A CN 201410020286A CN 103750318 B CN103750318 B CN 103750318B
- Authority
- CN
- China
- Prior art keywords
- powder
- soft capsule
- angelica keiskei
- ashitaba
- mixed
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000007901 soft capsule Substances 0.000 title claims abstract description 31
- 238000002360 preparation method Methods 0.000 title claims abstract description 12
- 239000000843 powder Substances 0.000 claims abstract description 45
- 238000002156 mixing Methods 0.000 claims abstract description 21
- 239000010497 wheat germ oil Substances 0.000 claims abstract description 18
- 235000013871 bee wax Nutrition 0.000 claims abstract description 8
- 230000001954 sterilising effect Effects 0.000 claims abstract description 6
- 239000002994 raw material Substances 0.000 claims abstract description 3
- 241001105098 Angelica keiskei Species 0.000 claims description 44
- 241000222336 Ganoderma Species 0.000 claims description 8
- 239000012166 beeswax Substances 0.000 claims description 6
- 238000007721 mold pressing method Methods 0.000 claims description 5
- 150000001875 compounds Chemical class 0.000 claims description 3
- 238000001035 drying Methods 0.000 claims description 2
- 238000007710 freezing Methods 0.000 claims description 2
- 239000003595 mist Substances 0.000 claims description 2
- 240000008397 Ganoderma lucidum Species 0.000 abstract description 4
- 235000001637 Ganoderma lucidum Nutrition 0.000 abstract description 4
- 239000000203 mixture Substances 0.000 abstract description 4
- 238000005096 rolling process Methods 0.000 abstract description 4
- 239000008280 blood Substances 0.000 abstract description 3
- 210000004369 blood Anatomy 0.000 abstract description 3
- 230000006870 function Effects 0.000 abstract description 3
- 230000036039 immunity Effects 0.000 abstract description 3
- 230000002633 protecting effect Effects 0.000 abstract description 2
- 230000002195 synergetic effect Effects 0.000 abstract description 2
- 241000220317 Rosa Species 0.000 abstract 3
- 239000011259 mixed solution Substances 0.000 abstract 2
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 230000032683 aging Effects 0.000 abstract 1
- 230000036772 blood pressure Effects 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- 238000007723 die pressing method Methods 0.000 abstract 1
- 238000001914 filtration Methods 0.000 abstract 1
- 239000011812 mixed powder Substances 0.000 description 6
- 230000000694 effects Effects 0.000 description 5
- 239000000463 material Substances 0.000 description 5
- 239000004480 active ingredient Substances 0.000 description 4
- 208000001953 Hypotension Diseases 0.000 description 3
- 230000003712 anti-aging effect Effects 0.000 description 3
- 239000003292 glue Substances 0.000 description 3
- 208000021822 hypotensive Diseases 0.000 description 3
- 230000001077 hypotensive effect Effects 0.000 description 3
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 2
- OIRDTQYFTABQOQ-KQYNXXCUSA-N adenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O OIRDTQYFTABQOQ-KQYNXXCUSA-N 0.000 description 2
- 230000001093 anti-cancer Effects 0.000 description 2
- 230000000259 anti-tumor effect Effects 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 230000002526 effect on cardiovascular system Effects 0.000 description 2
- 235000019197 fats Nutrition 0.000 description 2
- 235000020778 linoleic acid Nutrition 0.000 description 2
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 2
- 238000012856 packing Methods 0.000 description 2
- 240000007087 Apium graveolens Species 0.000 description 1
- 235000015849 Apium graveolens Dulce Group Nutrition 0.000 description 1
- 235000010591 Appio Nutrition 0.000 description 1
- 244000178993 Brassica juncea Species 0.000 description 1
- 235000011332 Brassica juncea Nutrition 0.000 description 1
- 239000002126 C01EB10 - Adenosine Substances 0.000 description 1
- DQFBYFPFKXHELB-UHFFFAOYSA-N Chalcone Natural products C=1C=CC=CC=1C(=O)C=CC1=CC=CC=C1 DQFBYFPFKXHELB-UHFFFAOYSA-N 0.000 description 1
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- MSFSPUZXLOGKHJ-UHFFFAOYSA-N Muraminsaeure Natural products OC(=O)C(C)OC1C(N)C(O)OC(CO)C1O MSFSPUZXLOGKHJ-UHFFFAOYSA-N 0.000 description 1
- 244000131316 Panax pseudoginseng Species 0.000 description 1
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 1
- 235000003140 Panax quinquefolius Nutrition 0.000 description 1
- 108010013639 Peptidoglycan Proteins 0.000 description 1
- 241000220222 Rosaceae Species 0.000 description 1
- 229930003779 Vitamin B12 Natural products 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 229960005305 adenosine Drugs 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000000879 anti-atherosclerotic effect Effects 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000032677 cell aging Effects 0.000 description 1
- 230000032823 cell division Effects 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 235000005513 chalcones Nutrition 0.000 description 1
- 235000019804 chlorophyll Nutrition 0.000 description 1
- 229930002875 chlorophyll Natural products 0.000 description 1
- ATNHDLDRLWWWCB-AENOIHSZSA-M chlorophyll a Chemical compound C1([C@@H](C(=O)OC)C(=O)C2=C3C)=C2N2C3=CC(C(CC)=C3C)=[N+]4C3=CC3=C(C=C)C(C)=C5N3[Mg-2]42[N+]2=C1[C@@H](CCC(=O)OC\C=C(/C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)[C@H](C)C2=C5 ATNHDLDRLWWWCB-AENOIHSZSA-M 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
- 229960001231 choline Drugs 0.000 description 1
- FDJOLVPMNUYSCM-WZHZPDAFSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+3].N#[C-].N([C@@H]([C@]1(C)[N-]\C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C(\C)/C1=N/C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C\C1=N\C([C@H](C1(C)C)CCC(N)=O)=C/1C)[C@@H]2CC(N)=O)=C\1[C@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]1[C@@H](O)[C@@H](N2C3=CC(C)=C(C)C=C3N=C2)O[C@@H]1CO FDJOLVPMNUYSCM-WZHZPDAFSA-L 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 235000004626 essential fatty acids Nutrition 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 229910052732 germanium Inorganic materials 0.000 description 1
- GNPVGFCGXDBREM-UHFFFAOYSA-N germanium atom Chemical compound [Ge] GNPVGFCGXDBREM-UHFFFAOYSA-N 0.000 description 1
- 235000008434 ginseng Nutrition 0.000 description 1
- 235000021384 green leafy vegetables Nutrition 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 235000001497 healthy food Nutrition 0.000 description 1
- 230000002218 hypoglycaemic effect Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229940055726 pantothenic acid Drugs 0.000 description 1
- 235000019161 pantothenic acid Nutrition 0.000 description 1
- 239000011713 pantothenic acid Substances 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 230000037452 priming Effects 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- 230000004206 stomach function Effects 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 230000008467 tissue growth Effects 0.000 description 1
- DQFBYFPFKXHELB-VAWYXSNFSA-N trans-chalcone Chemical compound C=1C=CC=CC=1C(=O)\C=C\C1=CC=CC=C1 DQFBYFPFKXHELB-VAWYXSNFSA-N 0.000 description 1
- 235000019163 vitamin B12 Nutrition 0.000 description 1
- 239000011715 vitamin B12 Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
- A23P10/00—Shaping or working of foodstuffs characterised by the products
- A23P10/30—Encapsulation of particles, e.g. foodstuff additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Mycology (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
一种明日叶混合软胶囊，该软胶囊的内容物由下述重量百分比的原料制成：明日叶粉13～25％；破壁灵芝孢子粉10～20％；无籽刺梨粉10～20％；小麦胚芽油47～54％；蜂蜡0～2％。上述明日叶混合软胶囊的制备方法包括以下步骤：1、将配比量的明日叶粉、破壁灵芝孢子粉和无籽刺犁粉混合过120目筛后，采用常规灭菌；将灭菌后的混合料与配比量的小麦胚芽油混合，或与配比量的小麦胚芽油及蜂蜡混合，制成混合液；2、将均质后的混合液按常规滚模压制法制备明日叶混合软胶囊。本发明利用明日叶的有效成分与破壁灵芝孢子粉、无籽刺犁粉进行协同作用，具有降血压血脂、提高免疫力、抗癌、抗衰老、保护心血管等功效。
Description
技术领域
本发明涉及保健食品，尤其涉及一种明日叶混合软胶囊及其制备方法。
背景技术
明日叶(Angelica keiskei Koidzumi)属于芹科类，又名长寿菜、八丈芹、海峰人参，原产于日本著名的长寿之乡八丈岛，为两年或多年生草本植物。明日叶的生长快速，生命力较强，大有“今日摘叶、明日又发芽”之势，故称之为“明日叶”。明日叶被誉为“21世纪的健康食品”，并且《本草纲目》中也肯定了明日叶的药用价值。
明日叶中含有丰富的维生素B12、叶绿素、16种人体所需的氨基酸、以及类黄酮、泛酸、胆碱、天然有机锗等物质，尤以查耳酮类黄色素化合物的含量最高。所以明日叶具有抗衰老、降血压血脂、抗癌和改善肠胃道功能等功效，其中降血压血糖效果最为明显。
目前市场上对明日叶的加工基本上为茶叶、汤料、微胶囊形式，未将其与保健防治功效进行协同，所以明日叶的有效成分得不到更好发挥，这在一定程度上会限制明日叶的应用。软胶囊是新发展起来的一种新剂型，系将油状药物溶液、混悬液、糊状物或粉末定量压注并包封于胶膜内，形成大小形状各异的密封胶囊，一般用压制法或滴制法制备。采用软胶囊包装方式既能防止氧气进入，提高胶囊内混合液活性成分的稳定性，延长储存期；可以掩盖明日叶混合液的不良气味；在体内，内容物迅速释放，有效成分的利用率和吸收率也得到提高；便于携带且服用方便。目前还未见有将明日叶与其他保健防治功效成分以软件囊包装方式，进行协同作用的报道。
发明内容
本发明的目的，就在于提供一种明日叶混合软胶囊及其制备方法。
为了达到上述目的，本发明采用了以下技术方案：
一种明日叶混合软胶囊，该软胶囊的内容物由下述重量百分比的原料制成：
上述明日叶混合软胶囊的制备方法，包括以下步骤：
2.1将配比量的明日叶粉、破壁灵芝孢子粉和无籽刺犁粉混合过120目筛后，采用常规灭菌；将灭菌后的混合料与配比量的小麦胚芽油混合，或与配比量的小麦胚芽油及蜂蜡混合，制成混合液；
2.2将均质后的混合液按常规滚模压制法制备明日叶混合软胶囊。
所述明日叶粉是将明日叶经杀青低温速冻后，干燥粉碎制得。
所述破壁灵芝孢子粉是粒度小于10μm的微粉。
本发明中的灵芝孢子粉中含有丰富的多糖肽、腺嘌呤核苷、蛋白质、酶类、哂元素等，破壁的灵芝孢子粉会是细胞壁内的有效成分充分裸露出来，可以更好地被人体吸收。灵芝孢子具有抗肿瘤、抗衰老、保肝解毒、保护心血管、治疗糖尿病等多重功效。
本发明中的无籽刺犁粉属蔷薇科，含有丰富的维生素C，具有调节机体免疫功能、延缓衰老、解毒、抗动脉粥样硬化和抗肿瘤等功能，
本发明中的小麦胚芽油含有丰富的天然维生素E和亚油酸。天然维生素E可促进细胞分裂，延迟细胞衰老，具有抗衰老功效；亚油酸是人体必需脂肪酸，可调节胆固醇代谢，参与组织生长与修复。小麦胚芽油具有增进耐力、精力、体力和调高反应灵敏度的作用。
本发明利用明日叶的有效成分与破壁灵芝孢子粉、无籽刺犁粉进行协同作用，具有降血压血脂、提高免疫力、抗癌、抗衰老、保护心血管等功效。
具体实施方式
下面以非限定性实施例对本发明作进一步说明。
实施例1
1.明日叶混合软胶囊内容物配方：
明日叶粉13g，破壁灵芝孢子粉20g，无籽刺犁粉20g，小麦胚芽油47g。
2.明日叶混合软胶囊的制备
将明日叶粉、灵芝孢子粉和无籽刺犁粉三种物料粉按上述比例配制后过120目筛，再采用常规灭菌，将灭菌后的混合粉与小麦胚芽油混合，使得混合粉均匀的悬浮于小麦胚芽油中；按常规工艺化胶，按现有滚模压制法制备明日叶混合软胶囊。
根据需要生产的软胶囊可灌装为内容物0.5g每粒等大小规格。
实施例2
1.明日叶混合软胶囊内容物配方：
明日叶粉16g，破壁灵芝孢子粉16g，无籽刺犁粉16g，小麦胚芽油50g，蜂蜡2g。
2.明日叶混合软胶囊的制备
将明日叶粉、灵芝孢子粉和无籽刺犁粉三种物料粉按上配方配制后过120目筛，再采用常规灭菌，将灭菌后的混合粉与小麦胚芽油和蜂蜡的混合液混合，使得混合粉均匀的悬浮于小麦胚芽油中，按常规工艺化胶，按现有滚模压制法制备明日叶混合软胶囊。
根据需要生产的软胶囊可灌装为内容物0.5g每粒等大小规格。
实施例3
1.明日叶混合软胶囊内容物配方：
明日叶粉25g，破壁灵芝孢子粉10g，无籽刺犁粉10g，小麦胚芽油54g，蜂蜡1g。
2.明日叶混合软胶囊的制备
将明日叶粉、灵芝孢子粉和无籽刺犁粉三种物料粉按上述比例配制后过120目筛，再采用常规灭菌，将灭菌后的混合粉与小麦胚芽油和蜂蜡的混合液混合，使得混合粉均匀的悬浮于小麦胚芽油中，按常规工艺化胶，按现有滚模压制法制备明日叶混合软胶囊。
根据需要生产的软胶囊可灌装为内容物0.5g每粒等大小规格。
Claims (1)
1.一种明日叶混合软胶囊，其特征在于，该软胶囊的内容物由下述重量百分比的原料制成：
所述明日叶粉是将明日叶经杀青低温速冻后，干燥粉碎制得；
所述破壁灵芝孢子粉是粒度小于10μm的微粉；
上述明日叶混合软胶囊的制备方法包括以下步骤：
1.1将配比量的明日叶粉、破壁灵芝孢子粉和无籽刺犁粉混合过120目筛后，采用常规灭菌；将灭菌后的混合料与配比量的小麦胚芽油混合，或与配比量的小麦胚芽油及蜂蜡混合，制成混合液；
1.2将均质后的混合液按常规滚模压制法制备明日叶混合软胶囊。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410020286.XA CN103750318B (zh) | 2014-01-16 | 2014-01-16 | 明日叶混合软胶囊及其制备方法 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410020286.XA CN103750318B (zh) | 2014-01-16 | 2014-01-16 | 明日叶混合软胶囊及其制备方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN103750318A CN103750318A (zh) | 2014-04-30 |
| CN103750318B true CN103750318B (zh) | 2015-07-08 |
Family
ID=50517771
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201410020286.XA Active CN103750318B (zh) | 2014-01-16 | 2014-01-16 | 明日叶混合软胶囊及其制备方法 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103750318B (zh) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113101272B (zh) * | 2021-04-09 | 2021-11-09 | 一力制药(南宁)有限公司 | 一种灵芝颗粒 |
Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101732375A (zh) * | 2010-01-11 | 2010-06-16 | 海南兰地高新科技有限公司 | 明日叶混合胶囊及其制备方法 |
| CN101791123A (zh) * | 2010-04-16 | 2010-08-04 | 贵州华南理工生物工程有限公司 | 富含维生素b与c的保健品及其制备方法 |
| CN101810340A (zh) * | 2010-04-23 | 2010-08-25 | 陈显刚 | 一种明日叶软胶囊 |
| CN102326776A (zh) * | 2011-08-31 | 2012-01-25 | 上海交通大学 | 明日叶保健咀嚼片及其制备方法 |
| CN102919933A (zh) * | 2012-11-16 | 2013-02-13 | 上海交通大学 | 一种无籽刺梨、明日叶复合饮料及其制备方法 |
| CN103005431A (zh) * | 2012-12-03 | 2013-04-03 | 上海交通大学 | 一种无籽刺梨-明日叶复合咀嚼片及其制备方法 |
-
2014
- 2014-01-16 CN CN201410020286.XA patent/CN103750318B/zh active Active
Patent Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101732375A (zh) * | 2010-01-11 | 2010-06-16 | 海南兰地高新科技有限公司 | 明日叶混合胶囊及其制备方法 |
| CN101791123A (zh) * | 2010-04-16 | 2010-08-04 | 贵州华南理工生物工程有限公司 | 富含维生素b与c的保健品及其制备方法 |
| CN101810340A (zh) * | 2010-04-23 | 2010-08-25 | 陈显刚 | 一种明日叶软胶囊 |
| CN102326776A (zh) * | 2011-08-31 | 2012-01-25 | 上海交通大学 | 明日叶保健咀嚼片及其制备方法 |
| CN102919933A (zh) * | 2012-11-16 | 2013-02-13 | 上海交通大学 | 一种无籽刺梨、明日叶复合饮料及其制备方法 |
| CN103005431A (zh) * | 2012-12-03 | 2013-04-03 | 上海交通大学 | 一种无籽刺梨-明日叶复合咀嚼片及其制备方法 |
Also Published As
| Publication number | Publication date |
|---|---|
| CN103750318A (zh) | 2014-04-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102550737A (zh) | 一种养颜保健茶 | |
| Promkum et al. | Anticlastogenic effect of Eryngium foetidum L. assessed by erythrocyte micronucleus assay | |
| CN103054909A (zh) | 一种缓解体力疲劳的胶囊及其制备方法 | |
| CN102940011A (zh) | 一种含有橄榄提取物的饼干 | |
| CN103750318B (zh) | 明日叶混合软胶囊及其制备方法 | |
| WO2011052935A3 (ko) | 토복령, 여주 및 동충하초 추출물을 유효성분으로 포함하는 혈당 강하용 조성물 | |
| CN104366457A (zh) | 一种山楂叶保健胶囊 | |
| CN101455392B (zh) | 一种能延缓衰老的营养保健品及其制备方法 | |
| CN103479566A (zh) | 保湿美白眼膜 | |
| CN103830280B (zh) | 一种螺旋藻提取物的制备方法 | |
| CN107836533A (zh) | 一种可外用养颜护肤的食用紫苏籽精油 | |
| CN104248570A (zh) | 一种苜蓿养颜爽肤水 | |
| CN103005467B (zh) | 一种保肝营养组合物及其保肝营养食品 | |
| CN102511810A (zh) | 复合保健品 | |
| CN103932179A (zh) | 一种缓解压力及护肝的保健食品及其二步发酵制备方法 | |
| CN104586902A (zh) | 一种超临界技术生产北虫草灵芝孢子粉软胶囊的方法 | |
| CN104814269B (zh) | 一种以植物废弃物制备饲料添加剂的方法 | |
| CN102302104A (zh) | 番茄红素蜂花粉及制法 | |
| CN105901722A (zh) | 一种预防老年痴呆症的南极磷虾油保健胶囊 | |
| CN105995985A (zh) | 核桃油口服液 | |
| KR101346738B1 (ko) | 아마씨와 강황을 혼합한 것에 다수의 보조식자재를 첨가한 건강식품 | |
| CN107536952A (zh) | 一种核桃油黄精软胶囊及其制备方法 | |
| CN103468489A (zh) | 一种红茶灵芝酒的生产方法 | |
| CN103651957A (zh) | 一种具有美容养颜功效的保健油 | |
| CN104893931A (zh) | 一种具有调节血脂功效的海洋功能性复合配制酒 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant |